12 Recent Findings About Long COVID That Researchers Are Tracking

7. Metabolic Dysfunction and Diabetes Risk

Emerging research has identified significant metabolic complications associated with Long COVID, including an increased risk of developing diabetes and other endocrine disorders that can persist long after the acute infection has resolved. Large-scale epidemiological studies have revealed that COVID-19 survivors face a substantially elevated risk of developing new-onset diabetes, with some research suggesting this risk may be increased by 40% or more compared to uninfected individuals. The mechanisms behind this increased diabetes risk appear to be multifaceted, involving direct viral damage to pancreatic beta cells that produce insulin, systemic inflammation that promotes insulin resistance, and stress responses that can disrupt normal glucose metabolism. Advanced metabolic studies have shown that many Long COVID patients develop insulin resistance even without progressing to full diabetes, suggesting widespread disruption of normal glucose homeostasis. Researchers have also documented changes in other hormonal systems, including thyroid dysfunction, adrenal insufficiency, and disruptions to sex hormone production, indicating that SARS-CoV-2 may have broad effects on the endocrine system. Studies using continuous glucose monitoring have revealed that some Long COVID patients experience significant glucose variability and postprandial (after-meal) glucose spikes that weren't present before their infection. Additionally, research has shown that COVID-19 can affect lipid metabolism, with some patients developing dyslipidemia (abnormal cholesterol and triglyceride levels) that may contribute to cardiovascular risk. These metabolic complications appear to be particularly pronounced in patients who were hospitalized with severe COVID-19, but have also been observed in those who experienced mild acute illness. The recognition of these metabolic effects has led to recommendations for routine metabolic screening in Long COVID patients and has prompted research into whether early intervention with lifestyle modifications or medications might prevent or reverse these complications.